| RS1567260747 |
PHKG2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXc, Glycogen storage disease IXc |
| RS1567261757 |
PHKG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IXc, Glycogen storage disease IXc |
| RS1567261889 |
PHKG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IXc, Glycogen storage disease IXc |
| RS1567262537 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1567262640 |
SCNN1G
|
Health Risk |
Pathogenic |
Pseudohypoaldosteronism, type IB3 |
| RS1567262786 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1567263114 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome |
| RS1567263168 |
CREBBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Rubinstein-Taybi syndrome, Inborn genetic diseases |
| RS1567263375 |
CLCN7
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 4, Autosomal recessive osteopetrosis 4 |
| RS1567263529 |
CREBBP
|
Health Risk |
Likely pathogenic |
Menke-Hennekam syndrome 1, Menke-Hennekam syndrome 1 |
| RS1567263724 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1567265093 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS1567265131 |
CREBBP
|
Health Risk |
Pathogenic |
Menke-Hennekam syndrome 1, Menke-Hennekam syndrome 1 |
| RS1567265203 |
CREBBP
|
Health Risk |
Pathogenic |
Menke-Hennekam syndrome 1, Menke-Hennekam syndrome 1 |
| RS1567268668 |
MPI
|
Health Risk |
Pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1567268682 |
MPI
|
Health Risk |
Pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1567269045 |
AP4E1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1567269316 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1567269757 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1567269945 |
CREBBP
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1567270052 |
LMF1
|
Health Risk |
Pathogenic |
— |
| RS1567270184 |
SCNN1G
|
Health Risk |
Pathogenic |
Liddle syndrome 2, Liddle syndrome 2 |
| RS1567276741 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS1567277287 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1567280099 |
ANKS3
|
Health Risk |
Pathogenic |
Short stature, Short stature |
| RS1567282497 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1567282634 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome |
| RS1567283195 |
STUB1
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 16, Autosomal recessive spinocerebellar ataxia 16 |
| RS1567287477 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1567287990 |
RPS15A
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 20, Diamond-Blackfan anemia 20 |
| RS1567294240 |
MEIS2
|
Health Risk |
Pathogenic |
— |
| RS1567295184 |
HEXA
|
Health Risk |
Pathogenic/Likely pathogenic |
Tay-Sachs disease, HEXA-related disorder |
| RS1567297439 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1567300736 |
ABAT
|
Health Risk |
Pathogenic |
Gamma-aminobutyric acid transaminase deficiency, Gamma-aminobutyric acid transaminase deficiency |
| RS1567300982 |
XYLT1
|
Health Risk |
Pathogenic |
Desbuquois dysplasia 2, Desbuquois dysplasia 2 |
| RS1567306142 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS1567309482 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1567309582 |
UMOD
|
Health Risk |
Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS1567309813 |
UMOD
|
Health Risk |
Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS1567309965 |
UMOD
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS1567310019 |
UMOD
|
Health Risk |
Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS1567310155 |
UMOD
|
Health Risk |
Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, UMOD-related disorder |
| RS1567310537 |
ABAT
|
Health Risk |
Pathogenic |
Gamma-aminobutyric acid transaminase deficiency, Gamma-aminobutyric acid transaminase deficiency |
| RS1567311211 |
SLC12A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bartter disease type 1, Bartter disease type 1 |
| RS1567311279 |
UMOD
|
Health Risk |
Likely pathogenic |
— |
| RS1567311288 |
UMOD
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS1567312671 |
ABAT
|
Health Risk |
Pathogenic |
Gamma-aminobutyric acid transaminase deficiency, Gamma-aminobutyric acid transaminase deficiency |
| RS1567314296 |
SLC12A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bartter disease type 1, Inborn genetic diseases |
| RS1567314662 |
TECPR2
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS1567316325 |
SALL1
|
Health Risk |
Pathogenic |
Townes syndrome, Townes syndrome |
| RS1567316655 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1567318022 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1567327347 |
IFT140
|
Health Risk |
Pathogenic/Likely pathogenic |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS1567327482 |
TECPR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia |
| RS1567328510 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS1567329011 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1567330535 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, IFT140-related disorder |
| RS1567331335 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome, CREBBP-related disorder |
| RS1567331357 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS1567335355 |
ABCA3
|
Health Risk |
Pathogenic |
Interstitial lung disease due to ABCA3 deficiency, Interstitial lung disease due to ABCA3 deficiency |
| RS1567337914 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Self-limited epilepsy with centrotemporal spikes, Landau-Kleffner syndrome |
| RS1567341422 |
SIN3A
|
Health Risk |
Pathogenic |
— |
| RS1567342899 |
TBX6
|
Health Risk |
Pathogenic |
Spondylocostal dysostosis 5, Spondylocostal dysostosis 5 |
| RS1567353425 |
SETD1A
|
Health Risk |
Likely pathogenic |
— |
| RS1567353500 |
SETD1A
|
Health Risk |
Likely pathogenic |
SETD1A-related disorder, SETD1A-related disorder |
| RS1567360969 |
CNGB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 45, Retinitis pigmentosa 45 |
| RS1567368243 |
SIN3A
|
Health Risk |
Pathogenic |
SIN3A-related intellectual disability syndrome due to a point mutation, SIN3A-related intellectual disability syndrome due to a point mutation |
| RS1567369247 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome |
| RS1567369975 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome |
| RS1567370223 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS1567370784 |
HSD3B7
|
Health Risk |
Pathogenic |
— |
| RS1567371518 |
HSD3B7
|
Health Risk |
Pathogenic |
— |
| RS1567373723 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS1567378099 |
STX1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS1567378779 |
MMP2
|
Health Risk |
Pathogenic |
Multicentric osteolysis, nodulosis |
| RS1567379016 |
PRRT2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS1567379470 |
STX1B
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1567379671 |
STX1B
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS1567379819 |
PRRT2
|
Health Risk |
Pathogenic |
Episodic kinesigenic dyskinesia, Episodic kinesigenic dyskinesia |
| RS1567380076 |
PRRT2
|
Health Risk |
Pathogenic |
Infantile convulsions and choreoathetosis, Infantile convulsions and choreoathetosis |
| RS1567380135 |
PRRT2
|
Health Risk |
Likely pathogenic |
Episodic kinesigenic dyskinesia, Episodic kinesigenic dyskinesia |
| RS1567380772 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1567381218 |
OTOA
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 22, Autosomal recessive nonsyndromic hearing loss 22 |
| RS1567386034 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1567386464 |
IFT140
|
Health Risk |
Likely pathogenic |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS1567386603 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567387207 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Lymphangiomyomatosis, Isolated focal cortical dysplasia type II |
| RS1567390809 |
LPCAT2
|
Health Risk |
Pathogenic |
Multicentric osteolysis nodulosis arthropathy spectrum, Multicentric osteolysis nodulosis arthropathy spectrum |
| RS1567394860 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567395826 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS1567396193 |
CNOT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Vissers-Bodmer syndrome, Vissers-Bodmer syndrome |
| RS1567396832 |
OTOA
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 22, Autosomal recessive nonsyndromic hearing loss 22 |
| RS1567398983 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567403619 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |
| RS1567404609 |
CLDN9
|
Health Risk |
Conflicting classifications of pathogenicity |
Pendred syndrome, Hearing loss |
| RS1567407044 |
IFT140
|
Health Risk |
Likely pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS1567408314 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567408727 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1567409292 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567411053 |
TBC1D24
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 65, Developmental and epileptic encephalopathy |